Fatal acute cardiomyopathy associated with “non-cardiotoxic” chemotherapy for autologous bone marrow transplantation
✍ Scribed by Jayesh Mehta; Arnon Nagler; David Schechter; A. J. J. T. Rein; Shimon Slavin
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 135 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To the Editor: Relapse is still a problem for leukemias, particularly in the autologous bone marrow transplantation (ABMT) setting. Moreover, the CD20 positive phenotype, de®ned as >20% expression, may be associated with a worse outcome [1]. Therefore, our experience with such a patient in whom we a
The purpose of this study was to evaluate the use of two cycles of
To investigate the possible implications of heterogeneity among the non-Hodgkin's lymphomas for bone marrow purging using complement-fixing monoclonal antibodies to lymphoma-associated antigens, a panel of large cell lymphoma cell lines of diverse phenotypes was treated with monoclonal antibodies DL